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Abstract We have previously cloned the human RNA polym-
erase II subunit 11, as a doxorubicin sensitive gene product. We
suggested multiple tasks for this subunit, including structural and
regulatory roles. With the aim to clarify the human RNA
polymerase II subunit 11 function, we have identified its
interacting protein partners using the yeast two-hybrid system.
Here, we show that human RNA polymerase II subunit 11
specifically binds keratin 19, a component of the intermediate
filament protein family, which is expressed in a tissue and
differentiation-specific manner. In particular, keratin 19 is a part
of the nuclear matrix intermediate filaments. We provide
evidence that human RNA polymerase II subunit 11 interacts
with keratin 19 via its N-terminal K motif, the same motif
necessary for its interaction with the human RNA polymerase II
core subunit 3. We found that keratin 19 contains two putative
leucine zipper domains sharing peculiar homology with the K
motif of human RNA polymerase II subunit 3. Finally, we
demonstrate that keratin 19 can compete for binding human
RNA polymerase II subunit 11/human RNA polymerase II
subunit 3 in vitro, suggesting a possible regulatory role for this
molecule in RNA polymerase II assembly/activity.
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1. Introduction
Eukaryotic heteromeric RNA polymerase II (pol II) is a
multisubunit enzyme comprised of 10^12 core polypeptides
[1]. Despite the fundamental role of pol II in mRNA tran-
scription, little information is available concerning the speci¢c
functions of its individual subunits. There is some evidence
suggesting that pol II in yeast may modulate transcription by
altering its subunit composition in response to nutrient or
thermal stress [2^4]. The issue of subunit variation in mam-
malian pol II has, however, not yet been investigated. We
have previously cloned the human RNA polymerase II sub-
unit 11 (hRPB11) and shown the involvement of this protein
in dox-mediated cellular toxicity and cellular di¡erentiation
[5^7], indicating that hRPB11 may exert a speci¢c role in
gene regulation. This subunit contains two amino acid se-
quences (K motif) with limited homology to the K subunit
of Escherichia coli RNA polymerase and it interacts with
hRPB3, another human RNA pol II K-like subunit [6,8].
The hRPB11 N-terminal K motif is necessary for this inter-
action and it appears to be the unique contact site of hRPB11
with pol II. The heterodimer hRPB11/3 is considered to be the
functional counterpart of the bacterial K subunit homodimer
[9,10]. This homodimer plays a role in promoter recognition
by interacting directly with sequence-speci¢c upstream DNA
elements and in transcriptional regulation by binding to spe-
ci¢c sets of transcription activator proteins [8,11,12]. In an
e¡ort to study the function of hRPB11, we used this subunit
as a bait in the yeast two-hybrid system to identify possible
interaction target protein(s). Here, we report the identi¢cation
of keratin 19 as a novel partner for hRPB11. Keratins are
members of the intermediate ¢lament (IF) family of structural
proteins [13]. IFs are dynamic structures that are involved in
signal transduction from the extracellular matrix to the nu-
cleus [14^18]. Keratins 8, 18 and 19 have been shown to be
present in the nuclear matrix-IF (NM-IF) [19,20]. These pro-
teins are bound to nuclear DNA in breast cancer cells sup-
porting the hypothesis that they are involved in the organiza-
tion of nuclear DNA. In particular, it has been suggested that
keratin 19 is involved in the epigenetic activation of new cel-
lular programs, through the rearrangement of the cytoskele-
ton, which may perturb the NM function [21,22].
Here, we show that keratin 19 shares peculiar homology
with the K motif of hRPB3. We provide evidence that
hRPB3 and keratin 19 interact with the same region of
hRPB11. Moreover, we demonstrate that keratin 19 can com-
pete for binding hRPB11/hRPB3.
2. Materials and methods
2.1. Yeast two-hybrid selection
For two-hybrid screening, the complete open reading frame of hu-
man RPB11 was cloned into a PstI restriction site of vector pGBT9
(Clontech, Palo Alto, CA, USA) in frame with the GAL4 binding
domain. Yeast strain HF7c [23], bearing UASg-His3 and UASg-
LacZ as reporter genes, was co-transformed with the bait pGBT9-
Hrpb11 and with a human skeletal muscle cDNA library (Clontech)
fused to the GAL4 activation domain in the vector pGAD10 (Clon-
tech). Transformation was performed using the lithium acetate meth-
od [24]. Cells were plated directly on minimal synthetic de¢ned (SD)
medium, 2% glucose, 0.67% Bacto yeast nitrogen base (Difco Labo-
ratories, Detroit, MI, USA), supplemented with the required bases
and amino acids, except tryptophan (Trp), leucine (Leu) and histidine
(His). Plates were incubated for 7 days at 30‡C, then, His trans-
formants were isolated. The His colonies, replica-plated on SD-
Leu-Trp-His medium and LacZ, were identi¢ed by a ¢lter-lifting
assay for L-galactosidase activity. Plasmid DNA was prepared from
candidate clones and electroporated into E. coli XLI-blue competent
cells (Stratagene, La Jolla, CA, USA). The recovered library-derived
plasmids were analyzed as positive candidates. The three constructs
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carrying di¡erent hRPB11 N-terminal deletions used in a two-hybrid
assay have been described elsewhere [6].
2.2. Co-precipitation with GST chimeric proteins, SDS-PAGE and
Western blotting analysis
The cDNA of keratin 19 isolated by screening was cloned into the
EcoRI restriction site of vector pGEX-4T1 (Pharmacia-Biotech) in
frame with the GST encoding sequence. LoVo H cells were lysed in
50 mM Tris-HCl pH 7.4, 250 mM NaCl, 5 mM EDTA, 50 mM NaF,
0.1 mM Na3VO4, 0.1% Triton X-100, 1 mM PMSF and 10 Wg/ml
leupeptin (lysis bu¡er) for 30 min at 4‡C. After centrifugation, super-
natants were transferred to a fresh tube and chimeric proteins GST-
keratin 19 conjugated to glutathione/Sepharose beads (Pharmacia-
Biotech, Milan, Italy) were added and incubated for 90 min at 4‡C.
Beads were washed three times in lysis bu¡er, dried and electropho-
resis sample bu¡er was added. The bound proteins were separated by
SDS-PAGE, transferred to PVDF membranes (Millipore) and probed
with anti-hRPB11 polyclonal antibody as previously described [5].
Immunoreactivity was detected by chemiluminescence reaction using
the ECL kit (Amersham, Milan, Italy).
2.3. In vitro transcription and translation
In vitro transcription and translation were performed using a TNT-
coupled reticulocyte lysate system (Promega) and L-[35S]methionine
(s 1000 Ci/mmol, Amersham) as directed by the manufacturer.
2.4. GST pull-down assays
For protein-protein interaction assays, comparable amounts of
resin-bound GST fusion proteins were incubated with in vitro trans-
lated proteins in NETN bu¡er (20 mM Tris-HCl, pH 8.0, 100 mM
NaCl, 1 mM EDTA and 0.5% NP-40) for 1 h at 4‡C. The resins
were then pelleted and extensively washed in the same bu¡er. The
bound proteins were separated by SDS-PAGE and the gel ¢xed,
incubated in Enlighting solution (Du Pont), dried and exposed for
£uorography.
3. Results
3.1. Yeast two-hybrid screen
An adult human skeletal muscle cDNA library was
screened with hRPB11 as bait by sequential transformation
of the appropriate yeast reporter strain HF7c. Of an estimated
1U106 transformants screened, 13 clones able to proliferate
on media lacking histidine and positive for L-galactosidase
staining were obtained. Eight of these positive clones were
identi¢ed as the pol II subunit hRPB3 [6], one encoded a
novel human protein, Che-1 (Fanciulli et al., personal com-
munication), and four were identi¢ed as keratin 19. The pos-
itives for keratin 19 were encoded by two clones of di¡erent
length, lacking di¡erent keratin 19 N-terminal portions and
named ker-cl1 and ker-cl2, respectively. ker-cl1 was repre-
sented by three identical clones encoding amino acids 38^
400 of keratin 19, while ker-cl2 was represented by a single
clone encoding amino acids 140^400 of the same protein. The
speci¢city of hRPB11/keratin 19 interaction was con¢rmed in
a two-hybrid assay performed by co-transforming the ker-cl2
clone with pGBT9/hRPB11 or with pGBT9/lamin and pGBT9
empty vector as a negative control. Fig. 1 shows that, whereas
pGBT9/hRPB11 was able to bind keratin19, pGBT9/lamin
and pGBT9 empty vector did not show any signi¢cant inter-
action.
3.2. hRPB11 interacts with keratin 19 in vitro
In order to con¢rm the results obtained with the two-hybrid
system, we produced a GST chimeric construct containing
ker-cl2, which was used in a co-precipitation assay. The glu-
tathione/Sepharose-GST and GST-ker-cl2 were added to a
LoVo H cell lysate that expresses high levels of hRPB11 [5].
Proteins that co-precipitated with the immobilized GST pro-
teins were analyzed by SDS-PAGE and in Western blots for
hRPB11. Results showed that, whereas GST alone did not
bind hRPB11, GST-ker2 co-precipitates large amounts of
hRPB11 (Fig. 2), con¢rming a speci¢c physical interaction
between keratin 19 and hRPB11.
3.3. Keratin 19 interacts with the N-terminal K motif of
hRPB11
We have previously demonstrated that hRPB11 interacts
with another human pol II subunit, hRPB3, via the N-termi-
nal K motif. To establish the portion of hRPB11 responsible
for the interaction with keratin 19, the ability of ker-cl2 to
Fig. 1. Human RPB11 binds keratin 19. HF7c yeast cells were co-transformed with the indicated plasmids and plated onto media lacking leu-
cine and tryptophan (3LW) to verify the expression of both bait (Trp) and prey (Leu) plasmids, onto a 3LW plate for assaying L-galactosi-
dase activity (not shown) or onto media lacking leucine, tryptophan and histidine (3LWH) for examining the interaction between bait and
prey proteins.
Fig. 2. Interaction of keratin 19 with a GST chimeric construct cor-
responding to hRPB11. LoVo H cell lysate was incubated with im-
mobilized GST or GST chimeric proteins, as indicated. Interacting
proteins recovered were fractionated by 12.5% SDS-PAGE, trans-
ferred onto a PVDF membrane and analyzed by Western blotting
for hRPB11.
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interact with three progressive amino-terminal truncated
hRPB11 derivatives was tested. As shown in Fig. 3, deletion
of 24 amino acids at the N-terminus failed to abrogate
hRPB11 interaction with pGAD10-ker-cl2, whereas deletion
of 54 amino acids containing the N-terminal K motif of
hRPB11 completely abrogated the binding capacity. There-
fore, hRPB11 requires its N-terminal K motif for interacting
with keratin 19.
3.4. Keratin 19 has putative leucine zipper motives sharing
signi¢cant homology to the K motif of hRPB3
The above results demonstrate that the hRPB11 N-terminal
K motif is able to interact with both hRPB3 and keratin 19
proteins. It has been demonstrated that hRPB3 binds hRPB11
essentially via its leucine-rich C-terminal K motif (Fanciulli et
al., personal communication). To determine whether a similar
domain was also present in keratin 19, the primary structure
of keratin 19 was analyzed using ScanProsite software. As
shown in Fig. 4A, two putative overlapping leucine zipper
motifs were found in keratin 19, with leucine residues involved
in periodic repetition at every seventh position. It is notewor-
thy that amino acid sequence comparison revealed a peculiar
homology between the keratin 19 leucine zipper region and
the hRPB3 K motif (Fig. 4B).
3.5. Keratin 19 competes with hRPB3 for the same binding site
of hRPB11
The indications that keratin 19 and hRPB3 bind the same
region of hRPB11 and the homology observed between the
keratin 19 leucine zipper region and the hRPB3 K motif led us
Fig. 3. hRPB11 interacts with keratin 19 by its N-terminal K motif. (A) Interaction analysis between keratin 19 and hRPB11 N-terminal deleted
constructs by a two-hybrid assay. (B) Schematic diagram of N-terminal deletions of the hRPB11 RNA polymerase II subunit. The horizontal
bars represent the amino acid sequence in each construct.
Fig. 4. Keratin 19 possesses two overlapping leucine zipper domains
that share homology with the K motif of hRPB3. (A) The two puta-
tive overlapping leucine zipper motifs present in the keratin 19 pro-
tein sequence. The leucine residues involved in the periodic repeti-
tion at every seventh position are indicated in bold/italic. (B) Amino
acid sequence similarity between keratin 19 and hRPB3.
Fig. 5. Keratin 19 competes with hRPB3 for the binding to
hRPB11. In vitro translated labelled hRPB3 was subjected to a
GST pull-down analysis using beads coated with GST or GST-
hRPB11 fusion protein. Prior to GST pull-down, beads were incu-
bated with keratin 19 as indicated.
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to hypothesize possible competition between these two pro-
teins for binding to hRPB11. To verify this hypothesis, we
tested the ability of GST-hRPB11 to bind 35S-labelled
hRPB3 in presence or in absence of keratin 19. Fig. 5 shows
that pre-incubation of GST-hRPB11 beads with keratin 19
produced a marked decrease in their ability to interact with
hRPB3. These data indicate that hRPB11 interacts with this
component of the IF family and that this interaction can
dissociate hRPB11 from pol II.
4. Discussion
RNA polymerase is a universal regulator of gene expres-
sion. The study of the pol II structure and how structural
details encode function is fundamental for an understanding
of the molecular mechanisms that regulate RNA polymerase
activity [25,26]. hRPB11 is a component of the RNA polymer-
ase multisubunit complex [27,28]. Although RPB11 is required
for cell viability in yeast [29], expression of this protein varies
in normal human tissues [5]. We have previously shown that
doxorubicin a¡ects hRPB11 expression and that this protein is
speci¢cally involved in doxorubicin-mediated toxicity. More-
over, we have demonstrated that ectopic expression of
hRPB11 a¡ects cell di¡erentiation, changing the cell prolifer-
ation rate and transactivating the speci¢c di¡erentiation
marker E-cadherin [5]. Taken together all these ¢ndings led
us to hypothesize a role of hRPB11 in gene regulation. In
order to investigate the hRPB11 function, we performed a
yeast two-hybrid experiment screening a human muscle
cDNA library, using hRPB11 as the bait. The result of this
experiment was the isolation of several hRPB11 interacting
proteins. In this paper, we report on the interaction of
hRPB11 with keratin 19, a component of the IF protein fam-
ily which forms part of the NM [14^18]. This strong interac-
tion, selected in yeast, was con¢rmed in a pull-down experi-
ment using human colon carcinoma cell lysate. Furthermore,
we demonstrate by a two-hybrid assay that the hRPB11 re-
gion involved in contacting keratin 19 contains the N-terminal
K motif. This motif appears to be responsible for the inter-
action between hRPB11 and pol II and is also responsible for
the interaction with hRPB3 [6]. Here, we demonstrate that
hRPB3 and keratin 19 preferentially compete with the N-ter-
minal K motif on hRPB11 protein for binding. We interpret
these data as suggesting that these alternative hRPB11 inter-
actions represent a novel pol II regulatory mechanism. In fact,
keratin 19 can bind and dissociates hRPB11 from pol II, thus
regulating its function. Keratin 19 possesses several intriguing
functional and structural features that further support this
hypothesis. Analysis of its primary structure revealed the pres-
ence of two canonical overlapping leucine zipper motifs ex-
hibiting signi¢cant homology to the basal cell hRPB3 K-like
motif. In epithelial cells, keratin 19 is expressed in a small
basal cell subpopulation that exhibits stem-cell-like character-
istics and appears to have peculiar assembly properties im-
parting unique characteristics to the basal cells that expresses
it [30]. Keratin 19 and keratin 8 and 18 are located to the
NM-IF fraction and associate with nuclear DNA in many cell
lines [20,21,31,32]. Inappropriate expression of keratin 19 cor-
relates with cellular transformation and with epigenetic acti-
vation of new cellular programs via the rearrangement of the
cytoskeleton and NM [33,34]. Interestingly, pol II in its hyper-
phosphorilated form also associates with NM [35] by interact-
ing with several matrix proteins [36,37]. Therefore, the novel
interaction between hRPB11 and keratin 19 described here
may play a key role in regulating the function of pol II.
The details of the mechanism and the potential regulatory
role of this interaction await further investigation.
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